788 results on '"Wick W."'
Search Results
2. Can Schrodingerist Wavefunction Physics Explain Brownian Motion? II. The Diffusion Coefficient
3. Can Schroedingerist Wavefunction Physics Explain Brownian Motion?
4. Patient, Relative and Staff Experiences of Clinical Trial Participation in Neurooncology: “Maybe You Can Also Show the Positive, No Matter How It Ends&rdquo
5. On Schr\'odingerist Quantum Thermodynamics
6. On Non-Linear Quantum Mechanics, Space-Time Wavefunctions, and Compatibility with General Relativity
7. Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
8. On Non-Linear Quantum Mechanics and the Measurement Problem IV. Experimental Tests
9. On Non-Linear Quantum Mechanics and the Measurement Problem III. Poincare Probability and ... Chaos?
10. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
11. On Non-Linear Quantum Mechanics and the Measurement Problem II. The Random Part of the Wavefunction
12. On Non-linear Quantum Mechanics and the Measurement Problem I. Blocking Cats
13. Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial
14. A.6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2)
15. How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors
16. Emerging targets for anticancer vaccination: IDH
17. Hirntumorimmuntherapie – Möglichkeiten und Herausforderungen der Personalisierung
18. Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
19. 29/m mit sekundär generalisiertem Krampfanfall: Vorbereitung auf die Facharztprüfung: Fall 51
20. NLGN4X TCR transgenic T cells to treat gliomas
21. PL01.4.A LATE BREAKING ABSTRACT: A LONG PEPTIDE VACCINE TARGETING THE CLONAL DRIVER MUTATION H3K27M IN ADULT PATIENTS WITH DIFFUSE MIDLINE GLIOMA
22. KS01.5.A LATE BREAKING ABSTRACT: LONG-TERM FOLLOW-UP OF PATIENTS WITH NEWLY DIAGNOSED IDH-MUTANT ASTROCYTOMA AFTER IDH1-VAC TREATMENT
23. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
24. Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
25. Immuntherapien bei Gliomen
26. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis
27. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
28. Leptomeningeal metastasis from solid tumours:EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
29. Primäre intrakranielle und spinale Tumoren
30. Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
31. Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
32. 185P Interim analysis of the EOGBM1-18 study: Strong immune response to therapeutic vaccination with EO2401 microbiome derived therapeutic vaccine + nivolumab
33. 170P EO2401 microbiome derived therapeutic vaccine + nivolumab +/- bevacizumab, in neoadjuvant, adjuvant and non-surgery linked treatment of recurrent glioblastoma: Phase I-II EOGBM1-18/ROSALIE study
34. Anästhesie zur Thrombektomie
35. PL02.1.A EO2401, a novel microbiome-derived therapeutic vaccine for patients with recurrent glioblastoma: ROSALIE study
36. P11.48.A Primary CNS lymphoma after CLIPPERS: a case series
37. JS08.6.A A connectivity signature for glioblastoma
38. OS08.2.A Three layers of neuronal-like mechanisms driving brain tumor invasion
39. KS05.6.A Oral DNA vaccination targeting VEGFR2 combined with the anti-PD-L1 antibody avelumab in patients with progressive glioblastoma - final results. NCT03750071
40. 303P EO2401 (EO) therapeutic vaccine for patients (pts) with recurrent glioblastoma (GB): Phase I/II ROSALIE study
41. OS07.5.A Report from the pooled analysis of the randomized trials NORDIC, NOA-8 and CE.6 on elderly patients with glioblastoma
42. P12.12.A Resolving the cellular architecture of infiltration zones in glioblastoma
43. 482P The prognostic impact of CDKN2A/B heterozygous deletions in meningioma: Insights of a multicenter analysis
44. 444O The prognostic impact of CDKN2A/B heterozygous deletions in IDH-mutant glioma
45. Personalisierte Gliomtherapie
46. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
47. Prognostic significance of genome-wide DNA methylation profiles within the randomised, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma
48. P13.01 Neuronal activity drives distinct invasion modes of glioma cells
49. Estimation of Wear and Lifetime for an Improved Turbine Operation
50. P07.04 Rapid-CNS2: Rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof of concept study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.